Spiliotaki M, Kallergi G, Nikolaou C, Xenidis N, et al. Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane. Cancer Chemother Pharmacol 2021 Jan 29. pii: 10.1007/s00280-020-04227.
PMID: 33515073